Tyra Biosciences, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Tyra Biosciences, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on May 28, 2026.
NASDAQ
Tyra Biosciences will hold its annual stockholders meeting on May 29, 2025, to elect directors and ratify the appointment of Ernst & Young LLP as its independent accounting firm.
NASDAQ
Tyra Biosciences announces its annual stockholders meeting to be held virtually on May 29, 2025, to elect directors and ratify the appointment of its independent accounting firm.
NASDAQ
Tyra Biosciences announces the appointment of two new independent directors, Susan Moran and S. Michael Rothenberg, along with updates to its Non-Employee Director Compensation Program.
NASDAQ
Tyra Biosciences will hold its annual stockholders meeting on May 29, 2024, to elect directors, ratify the appointment of Ernst & Young LLP, and approve an amendment to the company's certificate of incorporation.
NASDAQ
Tyra Biosciences will hold its annual stockholders meeting virtually on May 29, 2024, to vote on director elections, auditor ratification, and an amendment to the company's certificate of incorporation.